Only one previous study has investigated changes in the metabolic profile in RA after treatment with TNF-inhibitors showing an increase of hippuric acid, citrate, and lactic acid related to infliximab use, while increases in choline, phenylacetic acid, urea, creatine, and methylamine were observed after treatment with etanercept [45]. The gene discussed is TNF; the disease is rheumatoid arthritis.